• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙型肝炎筛查和咨询后,近期注射吸毒者的持续药物使用变化:一项纵向研究。

Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.

机构信息

Research Center, Centre Hospitalier de l'Université de Montréal.

出版信息

Clin Infect Dis. 2014 Mar;58(6):755-61. doi: 10.1093/cid/cit938. Epub 2013 Dec 20.

DOI:10.1093/cid/cit938
PMID:24363333
Abstract

BACKGROUND

Notification of hepatitis C virus (HCV) positive status is known to have short-term impacts on subsequent alcohol, drug use and injection behaviors among persons who inject drugs (PWID). It remains to be established whether postscreening behavioral changes extend over time for PWID and whether screening test notification has behavioral impacts among HCV-negative PWID. This study sought to longitudinally assess substance use and injection behaviors after HCV status notification among HCV seroconverters and HCV-negative PWID.

METHODS

Initially HCV-seronegative PWID (n = 208) were followed prospectively between 2004 and 2011 in Montreal, Canada. Semiannual screening visits included blood sampling and an interview-administered questionnaire assessing substance use and injection behaviors. Multivariable generalized estimating equation analyses were conducted to assess substance use and behavior changes over time and compare changes between HCV seroconverters and HCV-seronegative participants while adjusting for baseline characteristics.

RESULTS

Of the 208 participants (83% male; mean age, 34.7 years, mean follow-up time, 39 months), 69 (33.2%) seroconverted to HCV. A linear decrease in syringe sharing behavior was observed over time after HCV and status notification, whereas a 10% decrease for each additional 3 months of follow-up was observed for injection cocaine and heroin use among HCV seroconverters but not among HCV-seronegative PWID (P < .05). No significant changes were observed in alcohol use.

CONCLUSIONS

Our results indicate that notification of HCV-positive status is associated with reduced injection drug use among seroconverters. Among PWID deemed seronegative after screening, there is no sustained trend for change in risk behavior.

摘要

背景

已知丙型肝炎病毒(HCV)阳性状态的通知会对注射吸毒者(PWID)随后的酒精、药物使用和注射行为产生短期影响。目前尚不清楚 PWID 的这些行为变化是否会随着时间的推移而持续,以及 HCV 阴性 PWID 的筛查测试通知是否会对其行为产生影响。本研究旨在纵向评估 HCV 血清转换者和 HCV 阴性 PWID 接受 HCV 状态通知后的物质使用和注射行为。

方法

最初,2004 年至 2011 年间,208 名 HCV 血清阴性的 PWID 在加拿大蒙特利尔进行了前瞻性随访。每半年进行一次筛查访视,包括采血和访谈式问卷调查,评估物质使用和注射行为。多变量广义估计方程分析用于评估随着时间的推移物质使用和行为的变化,并在调整基线特征的情况下比较 HCV 血清转换者和 HCV 血清阴性参与者之间的变化。

结果

在 208 名参与者(83%为男性;平均年龄 34.7 岁,平均随访时间 39 个月)中,有 69 名(33.2%)发生了 HCV 血清转换。HCV 和状态通知后,共享注射器的行为呈线性下降,而 HCV 血清转换者的注射可卡因和海洛因使用量每增加 3 个月就会减少 10%,但 HCV 血清阴性的 PWID 则没有观察到这种变化(P<0.05)。酒精使用量没有明显变化。

结论

我们的结果表明,HCV 阳性状态的通知与血清转换者注射毒品使用的减少有关。在筛查后被认为是血清阴性的 PWID 中,没有持续的风险行为变化趋势。

相似文献

1
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.丙型肝炎筛查和咨询后,近期注射吸毒者的持续药物使用变化:一项纵向研究。
Clin Infect Dis. 2014 Mar;58(6):755-61. doi: 10.1093/cid/cit938. Epub 2013 Dec 20.
2
A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.一项关于丙型肝炎病毒检测及感染状况告知对注射吸毒者行为改变影响的纵向研究。
J Epidemiol Community Health. 2015 Aug;69(8):745-52. doi: 10.1136/jech-2014-205224. Epub 2015 Mar 26.
3
Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.急性 HCV 感染的吸毒者接受 HCV 评估和治疗后短期药物注射使用的变化。
Int J Drug Policy. 2017 Sep;47:239-243. doi: 10.1016/j.drugpo.2017.05.033. Epub 2017 Jun 4.
4
Does informing people who inject drugs of their hepatitis C status influence their injecting behaviour? Analysis of the Networks II study.告知注射吸毒者他们的丙型肝炎状况会影响其注射行为吗?网络II研究分析。
Int J Drug Policy. 2014 Jan;25(1):179-82. doi: 10.1016/j.drugpo.2013.08.005. Epub 2013 Sep 8.
5
Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.丙型肝炎病毒血清转换与注射吸毒者初级保健医生就诊的关系:初级保健在丙型肝炎预防综合方法中的潜在作用。
Int J Drug Policy. 2015 Oct;26(10):970-5. doi: 10.1016/j.drugpo.2015.04.013. Epub 2015 Apr 25.
6
High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.高丙型肝炎发病率与处方类阿片注射和多药物使用有关:评估丙型肝炎预防障碍。
Int J Drug Policy. 2017 Sep;47:61-68. doi: 10.1016/j.drugpo.2017.05.027. Epub 2017 Jun 27.
7
Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.丙型肝炎病毒感染高风险的注射吸毒者对初级保健医生的就诊情况:仍有改善空间。
J Viral Hepat. 2015 Oct;22(10):792-9. doi: 10.1111/jvh.12393. Epub 2015 Jan 14.
8
HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.HIV 感染者和风险、预防、以及注射吸毒者的检测行为——全国 HIV 行为监测系统,2009 年,美国 20 个城市。
MMWR Surveill Summ. 2014 Jul 4;63(6):1-51.
9
Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C.注射毒品者在丙型肝炎病毒感染治疗后的注射风险行为:澳大利亚急性丙型肝炎试验
Int J Drug Policy. 2015 Oct;26(10):976-83. doi: 10.1016/j.drugpo.2015.05.003. Epub 2015 May 21.
10
KIR2DL3⁺NKG2A⁻ natural killer cells are associated with protection from productive hepatitis C virus infection in people who inject drugs.KIR2DL3⁺NKG2A⁻ 自然杀伤细胞与注射吸毒者免受丙型肝炎病毒感染有关。
J Hepatol. 2014 Sep;61(3):475-81. doi: 10.1016/j.jhep.2014.04.020. Epub 2014 Apr 26.

引用本文的文献

1
Individual Heterogeneity and Trends in Hepatitis C Infection Risk Among People Who Inject Drugs: A Longitudinal Analysis.注射吸毒者中丙型肝炎感染风险的个体异质性和趋势:一项纵向分析
J Viral Hepat. 2025 Apr;32(4):e13999. doi: 10.1111/jvh.13999. Epub 2024 Sep 5.
2
Safe Injection Self-Efficacy is Associated with HCV and HIV Seropositivity Among People Who Inject Drugs in the San Diego-Tijuana Border Region.在圣地亚哥-蒂华纳边境地区,注射毒品者的安全注射自我效能感与丙型肝炎病毒和 HIV 血清阳性率相关。
AIDS Behav. 2024 Nov;28(11):3629-3642. doi: 10.1007/s10461-024-04433-9. Epub 2024 Jul 26.
3
Safe Injection Self-Efficacy is associated with HCV and HIV seropositivity among people who inject drugs in the San Diego-Tijuana border region.
在圣地亚哥 - 蒂华纳边境地区,安全注射自我效能与注射毒品者中的丙型肝炎病毒(HCV)和艾滋病毒(HIV)血清阳性有关。
medRxiv. 2024 May 22:2024.05.21.24307696. doi: 10.1101/2024.05.21.24307696.
4
Out-of-Hospital Treatment of Hepatitis C Increases Retention in Care among People Who Inject Drugs and Homeless Persons: An Observational Study.丙型肝炎的院外治疗可提高注射吸毒者和无家可归者的治疗依从性:一项观察性研究。
J Clin Med. 2021 Oct 26;10(21):4955. doi: 10.3390/jcm10214955.
5
Health programmes and services addressing the prevention and management of infectious diseases in people who inject drugs in Canada: a systematic integrative review.加拿大针对注射吸毒人群的传染病预防和管理的健康计划和服务:系统综合评价。
BMJ Open. 2021 Sep 23;11(9):e047511. doi: 10.1136/bmjopen-2020-047511.
6
Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida.在实施注射器服务计划后,佛罗里达州迈阿密的注射风险行为减少。
J Subst Abuse Treat. 2021 Aug;127:108344. doi: 10.1016/j.jsat.2021.108344. Epub 2021 Mar 3.
7
High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan.台湾地区人类免疫缺陷病毒感染者中丙型肝炎病毒感染者与非感染者对丙型肝炎病毒感染状态认知率均较高。
PLoS One. 2021 May 6;16(5):e0251158. doi: 10.1371/journal.pone.0251158. eCollection 2021.
8
Novel Routes of Potential Hepatitis C Virus Transmission among People Who Inject Drugs: Secondary Blood Exposures Related to Injection Drug Use.新型潜在丙型肝炎病毒传播途径:与注射吸毒相关的次要血液暴露。
Subst Use Misuse. 2021;56(6):751-757. doi: 10.1080/10826084.2021.1879149. Epub 2021 Mar 26.
9
Patients at a drug detoxification center share perspectives on how to increase hepatitis C treatment uptake: A qualitative study.戒毒中心的患者分享了提高丙型肝炎治疗参与度的观点:一项定性研究。
Drug Alcohol Depend. 2021 Mar 1;220:108526. doi: 10.1016/j.drugalcdep.2021.108526. Epub 2021 Jan 11.
10
Prevalence and high risk behaviours associated with HCV testing among people who inject drugs: a systematic review and Meta-analysis.注射吸毒人群中丙型肝炎病毒检测的流行率和高危行为:系统评价和荟萃分析。
Subst Abuse Treat Prev Policy. 2020 Aug 24;15(1):64. doi: 10.1186/s13011-020-00306-1.